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j ourna l homepage: http : / /www.sch iz rescogn i t ion.com/A vision science perspective on schizophreniaPerceptual impairments in schizophreniawere described as long ago
as 1903, when Kraepelin (1903) reported that patients demonstrated
incomplete perception of brieﬂy exposed objects on a laboratory task.
Despite this early beginning, and despite the fact that the visual system
is the most heavily researched area of cognitive neuroscience, there
have been far fewer studies of vision in schizophrenia than of other cog-
nitive functions (e.g., memory, cognitive control) (Silverstein and
Keane, 2011b). In recent years, however, reports have accumulated in-
dicating that visual processing impairments are both prevalent among
individuals with schizophrenia, and signiﬁcant in terms of advancing
knowledge regarding etiology, pathophysiology, phenomenology, and
course of illness. For example, approximately 25–30% of individuals
with schizophrenia report visual hallucinations (Waters et al., 2014),
and the number of patients reporting visual distortions (of brightness,
motion, form, and color) is over twice that high (Phillipson and Harris,
1985). Importantly, reliable and valid laboratorymeasures of processing
in these domains are available, and they have long histories of demon-
strating speciﬁc impairments in schizophrenia (Cadenhead et al.,
2013; Chen, 2011; Green et al., 2011; Silverstein and Keane, 2011a).
These subjective and laboratory manifestations of visual abnormality
are clinically signiﬁcant. For example, visual distortions are associated
with subjective distress and suicidal ideation (even after controlling
for other factors such as psychotic symptoms and auditory distortions)
(Grano et al., 2015). Laboratory-based markers of visual processing im-
pairments have been shown to be related to poorer detection of facial
affect (Tso et al., 2015; Turetsky et al., 2007), impaired reading ability
(Martinez et al., 2012), poorer real-world functioning (Green et al.,
2012; Rassovsky et al., 2011), and reduced short- (Silverstein et al.,
2013) and long-term (Silverstein et al., 1998) treatment response. Visu-
al abnormalities can also be observed in children, adolescents, and
young adults at high-risk for schizophrenia (Hebert et al., 2010; Koethe
et al., 2009; Mittal et al. in press; Revheim et al., 2014; Schubert et al.,
2005), and ﬁndings suggest that they may be particularly sensitive
(compared to other clinical phenomena) for predicting conversion to
the disorder among high-risk (Klosterkotter et al., 2001) and general-
population (Schubert et al., 2005) samples. Nevertheless, despite this
growing body of evidence, visual processingmeasures are still rarely in-
cluded in clinical trials or high-risk studies.
Because, as noted above, visual functioning is relatively well under-
stood in the normal brain, it has the potential to shed light on many as-
pects of brain dysfunction in conditions such as schizophrenia. For
example, because the basic architecture of local integrative circuitry, in-
volving pyramidal cells and inhibitory interneurons, is the same in all
regions of the cortex (Phillips and Singer, 1997), but expressed far less
densely (i.e., with less associated complexity) in visual cortex compared
to other regions (e.g., the frontal cortex) (Monaghan et al., 1989), visual
cortex can serve as a useful model of broader aspects of coordinatedhttp://dx.doi.org/10.1016/j.scog.2015.05.003
2215-0013/© 2015 The Authors. Published by Elsevier Inc. This is an open access article underbrain function (Douglas and Martin, 2007) and its breakdown (Phillips
and Silverstein, 2003). In addition, laboratory tasks that emphasize
local aspects of neural integration (e.g., those of gain control in vision)
(Huang et al., 2006), as well as those that involve long-range connectiv-
ity, e.g., frontal-parietal connectivity as it is involved in contour integra-
tion (Castellano et al., 2014; Dima et al., 2009), can be useful in
demonstrating the integrity of small- and large-scale networks in
schizophrenia. These examples of connectivity, as they apply to vision,
can also inform our models of speciﬁc symptom domains. Studies
have already demonstrated relationships between alterations in speciﬁc
processes (operationalized in reliable and valid laboratory tasks) and
symptom clusters, namely between: 1) reduced application of prior
knowledge to processing of sensory information and positive symptoms
(Keane et al., 2013); 2) poor gain control and negative symptoms (Keri
et al., 2005); and 3) reduced ability to organize visual information and
disorganized symptoms (Uhlhaas and Silverstein, 2005). Moreover,
theseﬁndings are consistentwith theories positing that reduced illusion
perception (which is observed in schizophrenia) and positive symp-
toms both reﬂect failures in Bayesian processing (i.e., altered predictive
coding) (Clark, 2013; Corlett et al., 2009), and that reduced perceptual
organization, poor selective attention, and formal thought disorder re-
ﬂect failures of dynamic coordination of brain activity (Phillips and
Silverstein, 2003). The link between abnormal gain control and negative
symptoms is less clear conceptually, and is in need of further explora-
tion. Overall, these ﬁndings highlight the potential for speciﬁc tasks to
be useful as biomarkers of illness-related processes in treatment devel-
opment studies and clinical trials.
Further information about schizophrenia has come from
recent studies of retinal and ocular functions. Retinal (e.g., electroretino-
graphic and retinal nerve ﬁber layer thickness) and ocular (e.g., eye
alignment; retinal venulewidth) abnormalities have been found in indi-
viduals with schizophrenia, as well as in unaffected offspring, and some
of these indices predict conversion to psychosis (see Silverstein and
Rosen, in press, this issue, for review). This work is important for two
reasons. One is that it suggests that for at least some individuals with
schizophrenia, abnormal visual processing begins as early as the retina.
Second, because the retina is part of the central nervous system, and be-
cause we know that the retinal changes observed in some neurological
disorders (e.g. multiple sclerosis, Parkinson's disease, Alzheimer's dis-
ease) parallel illness progression, progressive white and gray matter
loss, and cognitive decline (Martinez-Lapiscina et al., 2014; Ratchford
et al., 2013; Saidha et al., 2013; Satue et al., 2014; Sedighi et al., 2014;
Tian et al., 2011; Toledo et al., 2008), the question of whether, and to
what extent, retinal and ocular measures could serve as biomarkers of
changes in brain structure and function in schizophrenia is worthy of
study. This includes the question of the extent to which changes in
levels of dopamine and glutamate in the retina reﬂect disease processesthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
40and/or medication effects (Silverstein and Rosen, in press), as well as
the extent to which altered retinal function (as measured by, for exam-
ple, electroretinography) reﬂects altered brain neurotransmitter levels
(Lavoie et al., 2014), given that there are afferent projections from the
brain to the retina (Gastinger et al., 2006).
This issue of Schizophrenia Research: Cognition focuses on these and
related issues, and consists of papers that were presented, or grew out
of discussions, at a conference on vision in schizophrenia, organized
by Dr. Michael Herzog, at L’École Polytechnique Fédérale de Lausanne
(EPFL) in Lausanne, Switzerland in July 2014. The paper by Javitt de-
scribes this meeting and summarizes each of the presentations. The
paper by Silverstein and Rosen discusses ways in which schizophrenia,
or its treatment, affects ocular and retinal function, andhow this can im-
pact visual processing in the disorder. The study by Joseph et al. high-
lights an innovative data reduction strategy for genetic data, and
demonstrates how this can be useful in efforts to link speciﬁc single nu-
cleotide polymorphisms with aspects of perceptual impairment in
schizophrenia. Herzog and Brand review data on masking in schizo-
phrenia, and conclude that impaired performance on masking tasks is
amanifestation of awidespread impairment in neuromodulation, as op-
posed to abnormal activity in the magnocellular pathway. Schmack
et al. present results from a percept stabilization task that support the
hypothesis of altered predictive coding in vision in schizophrenia, and
its relationship to delusions – further evidence that vision can be used
toprobeBayesianprocessing abnormalities involved in higher-level dis-
turbances. The study described byGiersch et al. also approaches percep-
tion from a predictive coding perspective, and demonstrates that
patients have difﬁculty binding events in time, as well as in space, an
impairment that can affect the subjective experience of the continuity
of time. Tschacher et al. describe a study indicating that a reduced ap-
preciation of incongruity in visual images is associated with a reduced
perception of funniness in the same images, and so provide an addition-
al example of the behavioral signiﬁcance of perceptual changes.
Modenato and Draginsky provide an overview of schizotypy, and how
it relates to schizophrenia, with a focus on brain imaging ﬁndings.
Shaqiri et al. demonstrate backward masking impairments in patients,
students with self-reported schizotypal traits, and relatives, and show
that in patients, nicotine use can partly normalize task performance, es-
pecially in those who are older – a ﬁnding that can help clarify our un-
derstanding of the cognitive effects of nicotine. Roché et al.
demonstrate how the construct of intermittent degradation can account
for performance impairments in schizotypy, and describe how this can
be used to extend our understanding of perceptual and cognitive im-
pairments in schizophrenia.
Findings such as those noted in the ﬁrst three paragraphs above,
in addition to the novel work presented in this special issue, have
important implications for advancing translational research in
schizophrenia and other psychoses. Speciﬁc questions that have be-
come particularly relevant recently include: 1) Can, and should, vi-
sual processing impairments (in addition to those in visual acuity)
be treated in schizophrenia, or high-risk cases? If yes, how? 2) Can
the assessment of visual function via laboratory tasks, and/or clinical
assessment of visual distortions, inform the prediction of risk for
conversion/relapse, and/or treatment response? 3) Can screening
for retinal and ocular abnormalities be useful in identifying illness
risk and progression? The ﬁndings noted above also suggest direc-
tions for more basic research on schizophrenia, involving questions
such as: 1) In what ways can aspects of visual function be used as ex-
amples of canonical cortical computations that can help clarify as-
pects of brain function in cognitive domains involving less concrete
forms of information (e.g., abstract reasoning, planning)? 2) What
are the relationships between perceptual disturbances and clinical
symptoms, including both causal relationships and cases in which
both emerge from similar mechanisms? Relatedly, 3) which visual
changes are trait-like and associated with schizophrenia (including
its genetic liability); which are related to severity of positive,negative and/or disorganized symptoms; and which are related to
other symptoms (e.g., depression, anxiety) or activity in functional
dimensions (e.g., arousal, HPA axis functioning, positive and nega-
tive valence systems) that cut across current diagnostic categories,
as emphasized by the NIMH Research Domain Criteria initiative
(Cuthbert and Insel, 2010)? Generating answers to these questions
may further our understanding of schizophrenia, similar to the way
in which the intense focus on prefrontal cortex and hippocampal
functioning has done over the past 25 years.References
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